The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.


Updates from The Motley Fool

Latest updates on Abiomed from Fool.com.


Stock Performance

ABMD vs. S&P 500 | 2 Year Performance
View Interactive ABMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abiomed.
Current Price: $116.94
Prev Close: $117.40
Open: $117.00
Bid: $115.76
Ask: $125.00
Day's Range: $116.21 - $119.19
52wk Range: $67.80 - $124.72
Volume: 297,938
Avg Vol 474,224
Market Cap: $4.96B
P/E (ttm): 118.59
EPS (ttm): $0.99
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Abiomed.
CAPS Rating 4 out of 5
 
166 Outperform
33 Underperform
CAPS All Stars
 
27 Outperform
11 Underperform

How do you think Abiomed will perform against the market?



You pick for Abiomed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Minogue, CEO

68% Approve

Based on 22 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abiomed.

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT